BioCentury | Jul 30, 2012
Company News

Caprion Proteomics, Thallion, Chicago Growth Partners, Great Point Partners LLC deal

Investment firm Chicago Growth Partners acquired and recapitalized proteomic biomarker discovery company Caprion. Thallion, which had an undisclosed stake in Caprion, received about C$3.9 million ($3.9 million) in cash and will receive about C$583,000 ($577,520)...
BioCentury | Oct 8, 2007
Company News

APT Pharmaceuticals board of directors update

APT Pharmaceuticals Inc. , Burlingame, Calif. Business: Inflammation, Pulmonary, Transplant Appointed: Camille Samuels, managing director at Versant Ventures Management LLC; and David Kroin, managing director at Great Point Partners LLC WIR Staff Inflammation Pulmonary Transplant...
BioCentury | Jul 2, 2007
Company News

Thallion, Great Point Partners LLC proteomics news

Great Point purchased 80% of TLN's Caprion Proteomics GP subsidiary, which will be renamed Caprion Proteomics Inc. Caprion will retain all of TLN's proteomic assets including the CellCarta proteomics technology platform. TLN will have rights...
BioCentury | Aug 7, 2006
Company News

Biodel board of directors update

Biodel Inc. , Danbury, Conn. Business: Drug delivery Appointed: David Kroin, cofounder and a managing director of Great Point Partners LLC; Albert Cha, a managing partner of Vivo Ventures; and Samuel Wertheimer, a principal of OrbiMed...
BioCentury | Dec 5, 2005
Company News

Gentium board of directors update

Gentium S.p.A. (GNT), Villa Guardia, Italy Business: Biomanufacturing, Cardiovascular Appointed: David Kroin, managing director of Great Point Partners LLC WIR Staff Cardiovascular...
Items per page:
1 - 5 of 5
BioCentury | Jul 30, 2012
Company News

Caprion Proteomics, Thallion, Chicago Growth Partners, Great Point Partners LLC deal

Investment firm Chicago Growth Partners acquired and recapitalized proteomic biomarker discovery company Caprion. Thallion, which had an undisclosed stake in Caprion, received about C$3.9 million ($3.9 million) in cash and will receive about C$583,000 ($577,520)...
BioCentury | Oct 8, 2007
Company News

APT Pharmaceuticals board of directors update

APT Pharmaceuticals Inc. , Burlingame, Calif. Business: Inflammation, Pulmonary, Transplant Appointed: Camille Samuels, managing director at Versant Ventures Management LLC; and David Kroin, managing director at Great Point Partners LLC WIR Staff Inflammation Pulmonary Transplant...
BioCentury | Jul 2, 2007
Company News

Thallion, Great Point Partners LLC proteomics news

Great Point purchased 80% of TLN's Caprion Proteomics GP subsidiary, which will be renamed Caprion Proteomics Inc. Caprion will retain all of TLN's proteomic assets including the CellCarta proteomics technology platform. TLN will have rights...
BioCentury | Aug 7, 2006
Company News

Biodel board of directors update

Biodel Inc. , Danbury, Conn. Business: Drug delivery Appointed: David Kroin, cofounder and a managing director of Great Point Partners LLC; Albert Cha, a managing partner of Vivo Ventures; and Samuel Wertheimer, a principal of OrbiMed...
BioCentury | Dec 5, 2005
Company News

Gentium board of directors update

Gentium S.p.A. (GNT), Villa Guardia, Italy Business: Biomanufacturing, Cardiovascular Appointed: David Kroin, managing director of Great Point Partners LLC WIR Staff Cardiovascular...
Items per page:
1 - 5 of 5